PGP and Alzheimer disease: Despite the short incubation period, the activation of this pump mediated by these compounds demonstrates their potential for modulating P-gp transport activity, and thus for increasing Aβ efflux, suggesting a promising source of new P-gp activators, with potential to increase Aβ detoxification, in the scope of AD treatment and/or prevention.